The Epidemiology of Nonalcoholic Fatty Liver Disease: A Global Perspective

被引：543

作者：

Lazo, Mariana ^{[2
,3
]}

Clark, Jeanne M. ^{[1
,2
,3
]}

机构：

[1] Johns Hopkins Univ, Dept Med, Baltimore, MD USA

[2] Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD USA

[3] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA

来源：

SEMINARS IN LIVER DISEASE | 2008年 / 28卷 / 04期

关键词：

Nonalcoholic fatty liver disease; NAFLD; epidemiology; risk factors;

D O I：

10.1055/s-0028-1091978

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Nonalcoholic fatty liver disease (NAFLD) is an increasingly recognized cause of liver disease in the United States and worldwide. With obesity being an important risk factor universally, NAFLD is now receiving greater attention and is regarded as a public health issue. In addition, as a result of an aging population and the improving control of other major causes of chronic liver disease, such as hepatitis C and hepatitis B, the burden of NAFLD is expected to increase in years to come. Prevalence estimates of this disease vary widely across populations because of differences in methods for diagnosis and/or definition. New strategies for the prevention, diagnosis, and management will be required to alter the course of this disease.

引用

页码：339 / 350

页数：12

共 140 条

[1] Nonalcoholic fatty liver disease as a complication of insulin resistance [J].

Abdelmalek, Manal F. ;

Diehl, Anna Mae .

MEDICAL CLINICS OF NORTH AMERICA, 2007, 91 (06) :1125-+

[2] Familial aggregation of insulin resistance in first-degree relatives of patients with nonalcoholic fatty liver disease [J].

Abdelmalek, Manal F. ;

Liu, Chen ;

Shuster, Jonathan ;

Nelson, David R. ;

Asal, Nabih R. .

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2006, 4 (09) :1162-1169

[3] Portal fibrosis and hepatic steatosis in morbidly obese subjects: A spectrum of nonalcoholic fatty liver disease [J].

Abrams, GA ;

Kunde, SS ;

Lazenby, AJ ;

Clements, RH .

HEPATOLOGY, 2004, 40 (02) :475-483

[4] Obstructive sleep apnoea, glucose tolerance and liver steatosis in obese women [J].

Acarturk, G. ;

Unlu, M. ;

Yuksel, S. ;

Albayrak, R. ;

Koken, T. ;

Peker, Y. .

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2007, 35 (04) :458-466

[5] Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity [J].

Adinolfi, LE ;

Gambardella, M ;

Andreana, A ;

Tripodi, MF ;

Utili, R ;

Ruggiero, G .

HEPATOLOGY, 2001, 33 (06) :1358-1364

[6] Immune response towards lipid peroxidation products as a predictor of progression of non-alcoholic fatty liver disease to advanced fibrosis [J].

Albano, E ;

Mottaran, E ;

Vidali, M ;

Reale, E ;

Saksena, S ;

Occhino, G ;

Burt, AD ;

Day, CP .

GUT, 2005, 54 (07) :987-993

[7] Fatty liver: Experience from western India [J].

Amarapurkar, Anjali ;

Ghansar, Tanveer .

ANNALS OF HEPATOLOGY, 2007, 6 (01) :37-40

[8] How common is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences? [J].

Amarapurkar, Deepak N. ;

Hashimoto, Estsuko ;

Lesmana, Laurentius A. ;

Sollano, Jose D. ;

Chen, Pei-Jer ;

Goh, Khean-Lee .

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 (06) :788-793

[9] Insulin resistance, the metabolic syndrome, and nonalcoholic fatty liver disease [J].

Angelico, F ;

Del Ben, M ;

Conti, R ;

Francioso, S ;

Feole, K ;

Fiorello, S ;

Cavallo, MG ;

Zalunardo, B ;

Lirussi, F ;

Alessandri, C ;

Violi, F .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (03) :1578-1582

[10] Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis [J].

Angulo, P ;

Keach, JC ;

Batts, KP ;

Lindor, KD .

HEPATOLOGY, 1999, 30 (06) :1356-1362

← 1 2 3 4 5 6 7 8 9 10 →